Pharma giant Bayer Pharmaceuticals and Zydus Lifesciences have ended their 50:50 joint venture called Bayer Zydus Pharma Private Limited (BZPPL). Bayer has acquired the remaining 25% stake from Zydus to gain full ownership of the entity. The joint venture was formed in 2011 to leverage the strengths of both companies...